934282-60-7 Usage
Uses
Used in Pharmaceutical Industry:
(R)-1-(5-(3-Chlorophenyl)isoxazol-3-yl)ethanol is used as a potential therapeutic agent for its pharmacological activity. Its application is due to the compound's potential to interact with biological targets, which may lead to the development of new drugs for various conditions.
Used in Neuroscience Research:
(R)-1-(5-(3-Chlorophenyl)isoxazol-3-yl)ethanol is used as a research tool for understanding the mechanisms of neurological disorders and the development of novel treatments. Its application is based on the compound's potential to modulate specific receptors or pathways involved in brain function and disease.
Used in Drug Discovery:
(R)-1-(5-(3-Chlorophenyl)isoxazol-3-yl)ethanol is used as a lead compound in the drug discovery process. Its application is due to the compound's structural features, which may provide insights into the design of new drugs with improved efficacy and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 934282-60-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,2,8 and 2 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 934282-60:
(8*9)+(7*3)+(6*4)+(5*2)+(4*8)+(3*2)+(2*6)+(1*0)=177
177 % 10 = 7
So 934282-60-7 is a valid CAS Registry Number.
934282-60-7Relevant academic research and scientific papers
NEW PROCESS FOR THE PREPARATION OF 1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL] -ETHANONE AND (R) -1- [5- (3-CHLORO-PHENYL) - ISOOXAZOL-3-YL] -ETHANOL
-
Page/Page column 15-16, (2010/08/05)
The present invention provides a process for the preparation of the compound 1- [5- (3-chloro-phenyl) -isooxazol-3-yl] - ethanone: Wherein the compound 5- (3-chlorophenyl) -isooxazol-3- carboxylate is reacted with CH3MgX. The present invention also provid
MGLUR5 MODULATORS
-
, (2008/06/13)
The present invention is directed to compounds of formula (I) Wherein R1 to R5, X and Z are further defined in the description. The invention also relates to processes for the preparation of the compounds and to intermediates used in
5- (PHENYLISOXAZOLYLETHOXY) -TRIAZOL- 3 -YL SUBSTITUTED PYRIDINE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
-
Page/Page column 13; 20, (2008/06/13)
The present invention is directed to novel compounds of formula (I) / (I1) / (III), their use in therapy and pharmaceutical compositions comprising said novel compounds.
